Creative Biolabs supplies cell therapy products, human gene therapy products and certain devices related to cell and gene therapy. Our latest approach for genetically engineered cell therapy is currently exploring the use of engineered T cells, NK cells, macrophage or cytokine-induced killer cells to induce an effective immune response in cancer cells or viruses, and regulatory T cells to regulate inflammation.
Different types of cells can be employed to develop genetically engineered cell therapies and consequently inducing immune responses to tumor cells. Technically, genomic editing technology offers the possibility of designing such general-purpose donor cells in a controlled manner. We provide the following technologies but not limited to these.
To enhance tumor-killing activity
To accelerate your cellular and gene project
To meet your special needs in cellular and gene therapy
To accelerate efficient completion for your research project
To accelerate technology fusion strategies for cancer treatment
To serve for your industry on cellular and gene therapy
To be the leading technology research and development platform
To assist your research in gene therapy
With the cell and gene therapy lifecycle infrastructure and our expert team, Creative Biolabs are capable of offering multiple engineering services in cellular and gene therapy. We have a number of strategies to help you deal with the challenges that you may encounter in the development of cell and gene therapy. The cell and gene therapy will be safer, more effective, scalable and affordable if we can paly a part in accelerating your project. Our work is to stay ahead of the latest innovations in cell and gene therapy thus we are at your disposal anytime.
Please feel free to contact us and our team will contact you as soon as possible.
For Research Use Only | Not For Clinical Use
Download our brochure